News | Latest Breaking News Stories & Headlines

Pfizer has cut its full-year forecast for sales of its antiviral Covid treatment Paxlovid by about $7 billion

Pfizer, BioNTech shares fall on sales uncertainty

Shares of Pfizer and German partner BioNTech fell today after the US drugmaker slashed the sales forecast for its Covid vaccine and therapy last week, and some analysts said the reduction was bigger than expectations.

Business • 16 Oct 23

BioNTech said its quarterly net profit dropped to €502m, down from €3.7 billion a year earlier

BioNTech broadens scope as Covid shot sales slide

Germany's BioNTech, Pfizer's partner on Covid-19 vaccines, said today its first-quarter net income plunged on lower demand for the shots as it widens its work on cancer and other diseases.

Business • 08 May 23

The German biotech firm said on Tuesday it expects €13 billion to €17 billion in revenue accruing to it from the vaccine this year

BioNTech expects up to €17bn in vaccine revenue in 2022

BioNTech has said it would likely generate up to €17 billion in 2022 revenue from the Covid-19 vaccine it co-developed with Pfizer, pledging to spend earnings on development of cancer drugs and new vaccines.

Business • 11 Jan 22

The BioNTech-Pfizer vaccine has been delivered in less than a year

From the lab to the jab: The BioNTech-Pfizer vaccine

It was over breakfast on the wintry morning of 24 January that Ozlem Tureci and her husband Ugur Sahin decided, "we need to fire the starting gun on this".

Coronavirus • 26 Dec 20

A phial of the Pfizer/BioNTech Covid-19 vaccine

US FDA staff back Pfizer's coronavirus vaccine data

Pfizer has cleared the next hurdle in the race to get its Covid-19 vaccine approved for emergency use after the US Food and Drug Administration released documents that raised no new issues about its safety or efficacy.

Coronavirus • 08 Dec 20

Effective immunisation is seen as the main weapon against the pandemic (stock image)

Cabinet approves purchase of Moderna Covid vaccine

The Cabinet has approved an advance purchase agreement for 875,000 doses of the Covid-19 vaccine produced by Moderna.

Coronavirus • 01 Dec 20

Pfizer/BioNTech to seek emergency approval for vaccine

Pfizer and its partner BioNTech confirmed they will apply for emergency use authorisation for their coronavirus vaccine, becoming the first to do so in the US or Europe as the pandemic rages around the world.

Coronavirus • 20 Nov 20

The European Commission in talks with BioNTech-Pfizer to buy up to 300 million doses of a potential vaccine against Covid-19

EU enters final talks for BioNTech-Pfizer vaccine

The European Commission said today it had entered final stage talks with BioNTech-Pfizer to purchase up to 300 million doses of a potential vaccine against Covid-19.

Business • 09 Sep 20

Pfizer has taken a roughly $500m hit to sales due to a drop in visits to hospital or the doctor's office due to Covid-19

Pfizer raises forecast despite Covid-19 impact

Pfizer has today beaten analysts' estimates for second-quarter profit and raised its full-year earnings forecast.

Business • 28 Jul 20

Pfizer and Germany's BioNTech are among a handful of companies racing to develop a safe and effective vaccine for Covid-19

US to pay Pfizer $1.95 billion for Covid-19 vaccines

Pfizer and German biotech firm BioNTech will get $1.95 billion from the US government to produce and deliver 100 million doses of their Covud-19 vaccine candidate, the companies said today.

Business • 22 Jul 20

The drug is one of 17 being tested on humans in a frantic global race to find a vaccine

BioNTech and Pfizer's Covid-19 vaccine shows potential

A Covid-19 vaccine developed by German biotech firm BioNTech and US pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said today.

Business • 01 Jul 20

BioNTech